MicrosensDx specializes in molecular diagnostics for infectious diseases and sepsis, offering rapid nucleic acid extraction (RapiPREP) and novel sepsis prognostic tools (ox-PTX3). They provide sample collection, stabilization, and inactivation products,

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company developing liposomal-based therapies for treating cancers and diseases of the bladder, oral cavity, and esophagus.

LENSAR, Inc. is a medical device company focused on developing and commercializing advanced laser technology for refractive cataract surgery.

Juno Genetics is a specialized laboratory focused on preimplantation genetic testing (PGT) for in vitro fertilization (IVF) patients.

JenaValve Technology, Inc. is a medical device company focused on the development and commercialization of transcatheter aortic valve replacement (TAVR) systems, specifically the Trilogy™ Heart Valve System. The system is designed to treat patients with symptomatic, severe aortic regurgitation (AR) and aortic stenosis (AS) who are at high surgical risk.

Insulet Corporation specializes in wearable, tubeless insulin pump technology known as the Omnipod Insulin Management System. The company is dedicated to simplifying diabetes management through its discreet, automated, and tubeless delivery system.

Ignite Proteomics is a commercial-stage precision oncology company, acquired by Aditxt, Inc. (as of March 2026), that specializes in pathway-based assessment of the activated proteome to support cancer therapy selection.

Enodia Therapeutics is developing small-molecule therapies for targeted protein degradation. The company focuses on inhibiting the Sec61/translocon complex to degrade pathological proteins at the point of synthesis, targeting inflammatory diseases, immunology, and oncology.

Elevage Medical Technologies is a specialized investment platform to support growth-stage medical device and technology companies. Based in Austin, TX, it provides capital and strategic, operational support to enhance patient health outcomes and accelerate commercialization.

Blackstone Life Sciences (BXLS) is a premier private equity investment platform, part of The Blackstone Group, specializing in funding and accelerating development for life science products and companies. It focuses on late-stage clinical development, pharmaceutical collaborations, and medical technology.